Supplementary Information from ≪i>tmprss2-Erg</i> Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in <i>pten</i> and ≪i>tp53</i>-Mutated Prostate Cancer

Alexandra M. Blee,Yundong He,Yinhui Yang,Zhenqing Ye,Yuqian Yan,Yunqian Pan,Tao Ma,Joseph Dugdale,E. Wolfgang Kuehn,Manish Kohli,Rafael E. Jiménez,Yu Chen,Xu Wang,Liguo Wang,Haojie Huang

DOI: https://doi.org/10.1158/1078-0432.22469922

2023-01-01

Abstract:Supplementary Figures and Tables. /// Supplementary Figure 1. TP53 mutation status in human prostate cancer. /// Supplementary Figure 2. Genotypic and histological characterization of Pten/Trp53/ERG-altered mouse prostates. /// Supplementary Figure 3. Immunohistochemistry and immunofluorescent co-staining of key markers in serially-sectioned mouse prostate tissues. /// Supplementary Figure 4. Transcriptomic characterization of the Pten/Trp53/ERG-mutated mouse prostates. /// Supplementary Figure 5. Western blot analysis of expression of ERG downstream genes and E2F1 targets in human prostate cancer cells. /// Supplementary Figure 6. Analysis of expression of ERG-regulated genes and ERG chromatin binding at these gene loci in human prostate cancer PC-3 cells. /// Supplementary Figure 7. Palbociclib and enzalutamide treatment optimization in human prostate cancer cell lines. /// Supplementary Figure 8. Characterization of LNCaP-RF xenografts and mouse tumor-derived allografts. /// Supplementary Table 1. shRNA sequences. /// Supplementary Table 2. RT-qPCR primer sequences. /// Supplementary Table 3. ChIP-qPCR primer sequences. /// Supplementary Table 4. PCR genotyping primer sequences. /// Supplementary Table 5. Raw staining index scores for AR and ERG IHC of mCRPC human tissue microarray. /// References